A Safety Study of PC945 (Opelconazole) Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study)
Condition(s):Pulmonary AspergillosisLast Updated:January 12, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Pulmonary AspergillosisLast Updated:January 12, 2024Completed
Condition(s):Invasive Pulmonary AspergillosisLast Updated:April 19, 2021Not yet recruiting
Condition(s):Chronic Pulmonary AspergillosisLast Updated:February 14, 2024Active, not recruiting
Condition(s):Chronic Pulmonary AspergillosisLast Updated:December 6, 2023Recruiting
Condition(s):Invasive Pulmonary AspergillosisLast Updated:June 15, 2023Completed
Condition(s):Chronic Pulmonary AspergillosisLast Updated:January 20, 2017Unknown status
Condition(s):Invasive Pulmonary AspergillosisLast Updated:March 4, 2024Completed
Condition(s):Invasive Pulmonary AspergillosisLast Updated:September 23, 2021Completed
Condition(s):Chronic Cavitary Pulmonary AspergillosisLast Updated:February 22, 2012Completed
Condition(s):Chronic Pulmonary Aspergillosis; AspergillosisLast Updated:October 30, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.